BI-1347

CAS No. 2163056-91-3

BI-1347 ( BI1347 )

Catalog No. M13451 CAS No. 2163056-91-3

BI-1347 is a potent, selective inhibitor of CDK8/cyclinC with IC50 of 1 nM。

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 72 In Stock
10MG 115 In Stock
25MG 228 In Stock
50MG 417 In Stock
100MG 614 In Stock
500MG 1287 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BI-1347
  • Note
    Research use only, not for human use.
  • Brief Description
    BI-1347 is a potent, selective inhibitor of CDK8/cyclinC with IC50 of 1 nM。
  • Description
    BI-1347 is a potent, selective inhibitor of CDK8/cyclinC with IC50 of 1 nM; BI-1347 shows tumor growth inhibition in an in vivo xenograft model, BI-1347 is an excellent small molecule tool inhibitor for testing biological hypotheses in vitro and in vivo.
  • Synonyms
    BI1347
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK8
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2163056-91-3
  • Formula Weight
    356.43
  • Molecular Formula
    C22H20N4O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 120 mg/mL (336.68 mM), Need ultrasonic and warming ( < 1 mg/ml refers to the product slightly soluble or insoluble )
  • SMILES
    O=C(N(C)C)CN1N=CC(C2=CC=C(C3=CN=CC4=C3C=CC=C4)C=C2)=C1
  • Chemical Name
    2-(4-(4-(isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CDK5 inhibitor 20-22...

    CDK5 inhibitor 20-223 (CP 668863) potent, selective, ATP-competitive CDK2/5 inhibitor with IC50 of 6.0 and 8.8 nM for CDK2/CyclinE and CDK5/p35, with little to no activity against CDK1/4/6/7/9.

  • TBB

    TBB(NSC 231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2)with IC50s of 0.9 and 1.6 μM for rat liver and human recombinant CK2 respectively).

  • Alsteropaullone

    Alsteropaullone (9-Nitropaullone, NSC 705701) is a derivative of kenpaullone, ATP-competitive inhibitor of CDKs and GSK3β, inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E and Cdk5/p25 with IC50 of 35, 15, 200 and 40 nM.